Cargando…

Treatment discontinuation and rate of disease transmission in psoriasis patients receiving biologic therapy during the COVID-19 pandemic: A Canadian multicenter retrospective study

Detalles Bibliográficos
Autores principales: Georgakopoulos, Jorge R., Mufti, Asfandyar, Vender, Ron, Yeung, Jensen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: by the American Academy of Dermatology, Inc. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7361079/
https://www.ncbi.nlm.nih.gov/pubmed/32679279
http://dx.doi.org/10.1016/j.jaad.2020.07.021
_version_ 1783559338084794368
author Georgakopoulos, Jorge R.
Mufti, Asfandyar
Vender, Ron
Yeung, Jensen
author_facet Georgakopoulos, Jorge R.
Mufti, Asfandyar
Vender, Ron
Yeung, Jensen
author_sort Georgakopoulos, Jorge R.
collection PubMed
description
format Online
Article
Text
id pubmed-7361079
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher by the American Academy of Dermatology, Inc.
record_format MEDLINE/PubMed
spelling pubmed-73610792020-07-15 Treatment discontinuation and rate of disease transmission in psoriasis patients receiving biologic therapy during the COVID-19 pandemic: A Canadian multicenter retrospective study Georgakopoulos, Jorge R. Mufti, Asfandyar Vender, Ron Yeung, Jensen J Am Acad Dermatol Research Letter by the American Academy of Dermatology, Inc. 2020-10 2020-07-15 /pmc/articles/PMC7361079/ /pubmed/32679279 http://dx.doi.org/10.1016/j.jaad.2020.07.021 Text en © 2020 by the American Academy of Dermatology, Inc. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Research Letter
Georgakopoulos, Jorge R.
Mufti, Asfandyar
Vender, Ron
Yeung, Jensen
Treatment discontinuation and rate of disease transmission in psoriasis patients receiving biologic therapy during the COVID-19 pandemic: A Canadian multicenter retrospective study
title Treatment discontinuation and rate of disease transmission in psoriasis patients receiving biologic therapy during the COVID-19 pandemic: A Canadian multicenter retrospective study
title_full Treatment discontinuation and rate of disease transmission in psoriasis patients receiving biologic therapy during the COVID-19 pandemic: A Canadian multicenter retrospective study
title_fullStr Treatment discontinuation and rate of disease transmission in psoriasis patients receiving biologic therapy during the COVID-19 pandemic: A Canadian multicenter retrospective study
title_full_unstemmed Treatment discontinuation and rate of disease transmission in psoriasis patients receiving biologic therapy during the COVID-19 pandemic: A Canadian multicenter retrospective study
title_short Treatment discontinuation and rate of disease transmission in psoriasis patients receiving biologic therapy during the COVID-19 pandemic: A Canadian multicenter retrospective study
title_sort treatment discontinuation and rate of disease transmission in psoriasis patients receiving biologic therapy during the covid-19 pandemic: a canadian multicenter retrospective study
topic Research Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7361079/
https://www.ncbi.nlm.nih.gov/pubmed/32679279
http://dx.doi.org/10.1016/j.jaad.2020.07.021
work_keys_str_mv AT georgakopoulosjorger treatmentdiscontinuationandrateofdiseasetransmissioninpsoriasispatientsreceivingbiologictherapyduringthecovid19pandemicacanadianmulticenterretrospectivestudy
AT muftiasfandyar treatmentdiscontinuationandrateofdiseasetransmissioninpsoriasispatientsreceivingbiologictherapyduringthecovid19pandemicacanadianmulticenterretrospectivestudy
AT venderron treatmentdiscontinuationandrateofdiseasetransmissioninpsoriasispatientsreceivingbiologictherapyduringthecovid19pandemicacanadianmulticenterretrospectivestudy
AT yeungjensen treatmentdiscontinuationandrateofdiseasetransmissioninpsoriasispatientsreceivingbiologictherapyduringthecovid19pandemicacanadianmulticenterretrospectivestudy